End-of-life care and outcomes. Summary. by Southern California Evidence-Based Practice Center/RAND
Overview 
To evaluate progress in the field of end-of-life
care and clarify research priorities, the National
Institute of Nursing Research (NINR), with the
Agency for Healthcare Research and Quality
(AHRQ), commissioned this evidence report as
the basis for a State-of-the-Science Conference in
December 2004.  The need for such an
assessment is clear. More than 75 percent of
Americans now live past age 65, and 83 percent
of Americans now die while covered by
Medicare.1 In 2000, the average life expectancy
for Americans was 80 years for women and 74
years for men, compared to just 49 years in
1900.2 By 2050, life expectancy for women and
men will likely increase to 84 and 80,
respectively.3 A century ago, death came to most
Americans suddenly.  Today, many Americans live
their last years with a chronic health condition,
and about 40 million people, 15 percent of the
adult U.S. population, are limited in activities
from such a condition.4, 5 Population aging
patterns suggest that in the coming decades,
larger numbers of Americans will be coping with
serious impairments late in life. For the relatively
healthy, a care system focused on curing acute
intermittent illness is adequate. For persons living
with advanced, chronic disease, neither
prevention nor cure are ordinarily possible.
Instead, patients and families struggling with
serious illness have other concerns, including
managing pain and other symptoms, coordinating
care among multiple providers and settings,
ensuring that treatments reflect preferences and
balance benefits and harms as well as medical
appropriateness, achieving empathic
communication and care, fostering well-being
(including spiritual concerns), maintaining
function, and practically supporting family and
caregivers through illness and bereavement.
Reporting the Evidence
This report addresses the following key
questions:
1. What outcome variables are valid
indicators of the quality of the end-of-life
experience for the dying person and for
the surviving loved ones?
a. What individual outcome measures are
most strongly associated with overall
satisfaction with end-of-life care? 
b. What is the reliability and validity of
specific instruments for measuring
quality of life or quality of care at the
end-of-life?
2. What patient, family, and health care
system factors are associated with better
or worse outcomes at end of life? 
a. What individual patient factors (e.g., age,
gender, race/ethnicity, underlying illness,
education, etc.) are associated with better
or worse outcomes at end of life?
b. What family factors (e.g., relationship to
patient, race/ethnicity, etc.) are associated
with better or worse outcomes at end of
life, including both outcomes reported
by the family and how the family affects
outcomes experienced by the patient? 
c. What health care system factors (e.g., site
of care, type of provider, support services,
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23. What processes and interventions are associated with
improved or worsened outcomes?
a. What is the effectiveness of specific healthcare
interventions for improving specific outcomes in
patients at the end of life? 
b. Does effectiveness of specific interventions vary among
different populations?
4. What are future research directions for improving end-
of-life care?
Methodology
A multidisciplinary Technical Expert Panel (TEP) was
formed to assist the Southern California Evidence-based
Practice Center with its review and to guide the evidence
report. The TEP included leading scientists and clinicians in
nursing, gerontology, and palliative medicine, and others with a
broad knowledge of relevant research and policy issues in both
the United States and Europe.  Research reviewers included an
oncology nurse, an intensivist (a physician who specializes in
the care of critically ill patients), a general internist, palliative
care physicians, and gerontologists. 
The sponsors decided to focus only on adults and identified
as a priority the evaluation of interventions related to managing
symptoms, enhancing communication, enhancing spirituality,
withdrawing technology, facilitating family caregiving, and
enhancing grief resolution. A decision was also made to focus
on three clinical common, representative conditions.  Thus, as
an organizing principle, our analysis deliberately highlighted
evidence that illuminated the end of life as lived with cancer,
chronic heart failure, or dementia.  Cancer patients experience
a somewhat predictable decline and are often served by hospice
in their final weeks.  In contrast, patients with organ system
failure (e.g., congestive heart failure [CHF], chronic obstructive
pulmonary disease [COPD]) may experience stable but
impaired function punctuated by unpredictable, severe illness
and rather sudden death6-8 and are rarely served by hospice. In
further contrast, patients with dementia have prolonged
declines and often reside in nursing homes.9, 10 
TEP members were asked to prioritize potential topics for
the report based on relative importance at the end of life,
relationship to patient experience, feasibility, relevance to care
and policy, the availability of recent reviews on the topic, ability
of the topic to illuminate differences in the strength of research
in important clinical areas of palliative care, and modifiability
in clinical practice and policy.11 With the TEP’s assistance, we
decided to focus on the following topics: 
• Satisfaction with care.
• As patient-centered concerns, the symptoms of pain,
dyspnea, depression, anxiety, and behavioral symptoms
associated with dementia. 
• As family and caregiver concerns, caregiver burden
excluding bereavement.
• As health system concerns, continuity of care. 
• As a concern that requires coordinated action among
patients, caregivers, and the healthcare system, advance
care planning (ACP).  
Literature Search and Review
A comprehensive search of the medical literature was
conducted to identify studies addressing the key questions. Staff
reviewed relevant articles, compiled tables of study
characteristics and results, appraised the methodological quality
of the controlled trials, and summarized results. 
Sources for our review included MEDLINE®, the Cochrane
Database of Reviews of Abstracts of Effects (DARE), the
National Consensus Project for Quality Palliative Care, and
several recent systematic reviews from both Health Canada and
National Institute for Clinical Excellence (NICE), United
Kingdom. We also used the 2000 Toolkit of Instruments to
Measure End of Life Care (TIME).  Additional studies were
identified primarily through searches by U.S. National Library
of Medicine (NLM) staff, complemented by RAND library
searches. The searches were limited to published articles in the
English language, appearing in journals between the years 1990
through 2004, involving human subjects, and did not include
individual case reports. NLM staff conducted the first search of
PubMed® in April 2004.
At the title screening stage, citations that clearly met the
following criteria were excluded: studies that enrolled only a
pediatric population (age 18 years and under); those that were
case studies with fewer than 30 cases; those that did not
consider palliative care; those that enrolled a non-Western
population or were published in a non-English journal; reviews
that were not systematic; clinical trials of chemotherapy,
radiotherapy, stent, laser, endoscopy, or surgery (unless effects
of the interventions were considered beyond effects on the
primary disease process); descriptions of ethical, legal, or
regulatory issues; descriptions of research processes; editorials,
histories, personal narratives, and other descriptive non-clinical
articles; articles about professional education (unless clinical or
patient outcomes described); articles about organ
transplantation or donation; articles that presented data only
from prior to the mid 1980s; and studies in which the
outcomes were lab or radiological tests or other physiological
indicators. Approved titles moved on to an abstract screening
phase.  
The Report
Studies that satisfied the inclusion criteria are summarized in
the evidence tables. The evidence tables provide detailed
information about the study design, patient characteristics,
inclusion and exclusion criteria, interventions evaluated, and
the outcomes. The study sample size offers a measure of the
weight of the evidence.  Within the report, summaries of
systematic reviews and intervention studies appear in an
abbreviated form in tables, using summary measures of the
main outcomes. Narrative text summarizes the findings and
provides qualitative analysis in response to the key questions for
each topic area.  
Peer Review 
Nine peer reviewers and TEP members reviewed our report.




Of the 21,745 titles identified through literature searches,
5,563 were considered to be of possible relevance and subject to
abstract review.  The literature search of the DARE abstracts
identified 92 titles; 62 were considered potentially relevant to
our topic areas and proceeded to abstract review. Another 71
were added to the library of abstracts from the NICE
guidelines, the Health Canada reports, the Toolkit of
Instruments to Measure End of Life Care, and the files of our
content experts. After eliminating duplicates and considering
only citations for which an abstract was available, a total of
5,165 abstracts were reviewed.
Responses to Questions
Key Question 1a. What individual outcome measures are
most strongly associated with overall satisfaction with end-of-
life care? 
Key Question 1b. What is the reliability and validity of
specific instruments for measuring quality of life or quality of
care at the end of life?
We identified 10 systematic reviews, 12 intervention studies,
and 17 observational studies on the subject of end-of-life care
and patient or caregiver satisfaction. The preponderance of the
interventional and observational literature supports the
effectiveness of palliative care for improving both patient and
caregiver satisfaction. Subjective measures of the end-of-life care
experience include both satisfaction and quality-of-care
measures, and these tools overlap significantly. Satisfaction or
quality-of-care instruments that assess focused aspects of end-
of-life care have been most useful in demonstrating the effects
of interventions. Nonspecific satisfaction instruments or studies
that use measures not specifically adapted for or developed for
palliative care settings have often demonstrated ceiling effects.
Possibly for that reason, effects of interventions on satisfaction
have been somewhat inconsistent. 
Measures of satisfaction that are more specific and strongly
related to explicit intervention aims or processes (e.g.,
communication, pain control, practical support and enhanced
caregiving) have demonstrated greater sensitivity to change and
support a process-outcome relationship among these variables.
The relationship of other processes or attributes of care (e.g.,
treatment of symptoms other than pain, spiritual support,
continuity and coordination of care) to satisfaction is less
evident in the literature, although such relationships are
supported qualitatively.  The ability to demonstrate
relationships between these aspects of care and satisfaction may
be partially related to challenges in defining spiritual support as
an intervention and measuring spiritual support and continuity
of care.
With regard to measures, our review identified one high-
quality, widely recognized resource (Toolkit of Instruments to
Measure End of Life Care) available on the World Wide Web
at www.chcr.brown.edu/pcoc/bibliographies.htm that
systematically reviewed and compiled recommended
instruments for end-of-life research up to the year 2000. We
updated and superceded this review, identifying 48 new
measures to supplement the 35 existing recommended
measures within the Toolkit.  Measure development is most
advanced for cancer populations or mixed populations that
consist largely of cancer patients. The largest number of
measures evaluated quality of life, quality of care, and
symptoms. The literature documents many measurement
challenges including proxy respondents, timing of interviews,
and cognitive thresholds. 
Key Question 2a: What individual patient factors are
associated with better or worse outcomes at the end of life?
Key Question 3a: What is the effectiveness of specific
healthcare interventions for improving specific outcomes in
patients at the end of life?
As our outcomes, we considered the specific symptoms of
pain, dyspnea, depression and anxiety, and behavioral effects of
dementia, as well as caregiver burden.  We reviewed 27
systematic reviews or meta-analyses because they addressed
selected symptoms of a palliative care population.  Of those 27,
we identified 12 that addressed the project questions and met
implicit quality criteria. Two of the reviews included here
focused specifically on a cancer population, one focused on
patients with COPD, three focused on patients with dementia,
and another six did not limit their reviews to only one disease
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4cohort.  We also reviewed 18 intervention studies and 14
observational studies that fulfilled our criteria.
The evidence base supporting the effectiveness of
interventions for cancer pain is quite strong, but additional
descriptive information about the experience of pain at the end
of life for conditions other than cancer is needed. Studies of
opioid treatment to relieve cancer pain were among the
strongest in terms of study design.  Few complementary and
alternative medicine (CAM) interventions had a beneficial
impact on pain relief; acupuncture and massage produced
short-term pain relief in cancer patients.  Studies of non-
pharmacologic interventions—both CAM and mainstream—
are small and of varied quality. None of the review studies and
only four of the intervention studies included non-cancer
patients; none of these studies focused on a single disease.  
Several small, promising studies support the beneficial effect
of opioids on dyspnea; one meta-analysis and three intervention
studies reported mostly beneficial results for cancer and
COPD. Relatively few studies have described the experience of
dyspnea, despite the fact that dyspnea is a characteristic
symptom of several important end-of-life conditions (e.g.,
advanced cancer, COPD, CHF).  The evidence from the
reviews and individual intervention studies does not strongly
support a role for oxygen therapy in the management of
dyspnea in cancer patients.  Exercise interventions may have a
beneficial effect on those with severe COPD and CHF but
have not been tested in cancer patients.  In small, short-term
studies, acupuncture, acupressure, and relaxation therapy
showed some clinical benefit.  
Effective interventions have targeted the pharmacologic
treatment of depression in cancer, but relatively few studies
have evaluated short-acting drugs (e.g., non-Selective Serotonin
Reuptake Inhibitors [SSRIs]) or the treatment of depression in
non-cancer conditions.  We identified one extensive review of
the intervention literature regarding depression treatment in
cancer patients.  Of the seven interventions considered by this
review, five focused on cancer patients. The other review and
two intervention studies focused on other disease cohorts (one
study focused specifically on depression in CHF patients, the
other on mixed disease). SSRI’s have been shown to be effective
in treating depression in palliative care populations. Behavioral
and CAM interventions have demonstrated mixed results.
Given the potential survival time after a diagnosis of
dementia, it is not clear what proportion of the populations in
studies evaluating interventions for behavioral problems in
dementia are clearly near the end of life.  The literature
addresses many symptoms including aggressive/disruptive
behavior, agitation, wandering, and mood lability.  These
studies suggest that a variety of non-pharmacologic therapies
may be effective. Pharmaceutical interventions were the subject
of only a few studies we identified and produced mixed results.
Because the literature on dementia is beset by many
methodological limitations, it is difficult to make definitive
statements about the best treatment for these patients.
With regard to burdens of caregiving other than
bereavement, we identified eight systematic reviews and meta-
analyses that were relevant to family or informal caregiving.
Three dealt with outcomes of caregivers for patients with
dementia or other chronic illness, while five dealt with cancer
patients or other life-threatening illnesses. We identified 13
additional studies assessing interventions and caregiver burden
and 18 observational studies. Of these, seven studies evaluated
the effect of caregiving interventions on terminally ill patients,
nine studies investigated the impact of two critical transitions
faced by many caregivers (nursing home placement or the
death of the care recipient, and only two studies examined the
needs of terminally ill non-cancer patients and their caregivers.
In general, a variety of interventions were studied for a broad
range of caregivers (e.g., spouses, adult children, others),
primarily caregivers to dementia patients.12, 13 Palliative care
caregiver interventions were studied mostly in terminal cancer
patient caregivers,14-17 usually as a supplement to clinical
palliative care services being provided to the terminally ill
patient.  Most studies, whether on dementia or end-of-life
caregiver interventions, focused on caregiver burden (objective
and subjective burden) as the main outcome measure, but
outcomes also included psychological distress (stress,
depression), anxiety, coping skills, life satisfaction, health related
quality of life, satisfaction with services or care, morale, rate of
patient home death, rates of patient institutionalization, and
costs.  
Two kinds of interventions were used to address caregiver
burden: individual and group interventions.  The interventions
included education, counseling, support groups, home health,
hospice, or palliative care services to caregivers, singly, or in
some combination.  For the most part, intervention studies
have reported inconsistent results.  Larger treatment effects have
been found for individual interventions, although group
interventions predominate in the literature.  Multi-component
interventions and some respite services have shown positive
(though small) impacts on caregiver burden. The
inconsistencies in the literature may be attributable to the
differences in the caregiver outcome measurement, research
design, and analytical methods used. 
With regard to continuity of care, we identified 9 systematic
reviews that potentially dealt with the subject of continuity. We
identified an additional 20 intervention studies and 17 relevant
observational studies that met our criteria. A preponderance of
evidence from systematic reviews and interventions support the
efficacy of interventions to improve continuity of palliative
 
cancer care. In addition, we found some lower quality evidence
that palliative HIV care could improve continuity of care.
Interventions embody a variety of successful approaches
including aspects of management, informational, and
interpersonal continuity as well as comprehensive integrated
care such as palliative care services. We found evidence for the
effectiveness of interventions targeting care at multiple levels—
provider, patient, provider/patient interface, and multiple
settings but particularly home and hospital. Our review is
limited in that it identified no evidence related to improving
continuity across multiple sites of care. 
Although we identified many effective interventions for
improving continuity in CHF care, few of these explicitly
addressed or reported patient-centered palliative outcomes (e.g.,
improvement in dyspnea, greater advance care planning,
caregiving impact). However, interventions that improved
continuity (often measured as hospital re-admission) share
features of successful interventions in general, including longer
intervention periods, coordination among providers, and
regular, structured home assessment. Many CHF interventions
specifically excluded patients who were ‘terminally ill,’ limiting
their generalizability.  Most interventions have targeted re-
admission to the hospital or other kinds of high cost care, but
interventions are needed to understand how to improve
continuity in other settings as well.
The usual practice of advance directives and advance care
planning is supported by little reliable scientific evidence of
efficacy in improving outcomes.  Improved communication
and planning has some tendency toward improved patient and
family satisfaction, and certainly anecdotes and small series
point to patient and family frustration and disappointment
with seriously flawed communication.  Nevertheless, high
quality research designs have not often been applied to these
questions and, when applied, have shown quite modest effects,
even upon increasing the rate of making decisions in advance.
Whether improved advance care planning actually improves the
experience for patients and their families has only thin and
equivocal evidence.  
Recommendations and Future Research
Our literature review identified a very large and diverse body
of literature reflecting the tremendous growth and importance
of the field of end-of-life care over the last decade. This review
of the scientific evidence underlying key parts of the field of
end-of-life care illuminates strengths of the field as well as
opportunities for research.  We identified evidence supporting
the association of satisfaction and quality of care with pain
management, communication, practical support and enhanced
caregiving. The literature review identified evidence to support
the effectiveness of interventions to improve satisfaction;
ameliorate cancer pain, relieve depression in cancer, non-
pharmacologic interventions for behavioral problems in
dementia, and foster continuity in cancer and CHF care.
Evidence is strongest in cancer reflecting the degree to which
palliative care has already been integrated into the research
agenda and clinical practice of oncology. 
We also identified several opportunities for future research to
strengthen the evidence base for end-of-life care. Our
recommendations are as follows:
1. Research would benefit from characterizing the
implications of alternative conceptual and operational
definitions of the “end of life,” particularly for important
conditions. Efforts to define populations with specific
symptoms, informational and caregiver needs, and risks of
discontinuity are needed.
2. Further measure development should emphasize testing
the highest quality measures in important settings (e.g.,
hospital, nursing home, hospice, and ambulatory care).
These measures need to be evaluated in diverse
populations (e.g., racial/ethnic groups, non-cancer
conditions). 
3. Studies evaluating satisfaction should use specific measures
that reflect processes of care, and studies should examine
the relationship of satisfaction to less studied processes
such as non-pain symptoms, spiritual support, and
continuity.
4. Methodological challenges in measurement require
focused research. Strengthened research infrastructure
including collaborative networks should be considered.
5. Symptoms have been relatively well-characterized in
cancer, but high-quality studies of the incidence and
epidemiology of pain and other symptoms, the
relationship among symptoms, and the clinical
significance of symptoms are needed in non-cancer
conditions.
6. Small, high-quality studies suggest the effectiveness of
interventions to alleviate dyspnea. Larger studies of
interventions to alleviate dyspnea in cancer and non-
cancer conditions are needed.
7. Studies that evaluate short- as well as long-term treatment
of depression in palliative care settings are needed.
8. Research supports the effectiveness of interventions for
cancer and dementia caregiving. High-quality studies in
other populations are needed. These studies need to pay
special attention to methodologic issues such as careful,
specific measurement of outcome variables. 
9. The economic and social dimensions of caregiving need
additional research.
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610. Substantial evidence supports interventions to improve
continuity between home and hospital. Continuity
research needs to look at other settings in which most
patients are cared for, e.g., ambulatory care. Additional
study of nursing home-hospital continuity and studies
that incorporate multiple settings and providers are
needed. 
11. Studies of continuity in CHF and other conditions should
incorporate the palliative domains described above (e.g.,
physical and psychological symptoms, caregiver burden,
advance care planning) and need to be more generalizable
to the sickest patients. Such studies need to include
patients with multiple comorbidities.
12. Rigorous research in advance care planning is needed to
understand how to best achieve patient and family goals
(as opposed to evaluating resource allocation), and such
research needs to address fundamental processes of care
planning.
Availability of the Full Report
The full evidence report from which this summary was taken
was prepared for the Agency for Healthcare Research and
Quality (AHRQ) by the Southern California Evidence-based
Practice Center, under Contract No. 290-02-0003. It is
expected to be available in December 2004. At that time,
printed copies may be obtained free of charge from the AHRQ
Publications Clearinghouse by calling 800-358-9295.
Requesters should ask for Evidence Report/Technology
Assessment No. 110, End-of-Life Care and Outcomes.  In
addition, Internet users will be able to access the report and this
summary online through AHRQ’s Web site at www.ahrq.gov.
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